SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Philip Kiely, Screening blood donors for hepatitis C virus: the challenge to consider cost-effectiveness, Transfusion, 2015, 55, 6
  2. 2
    Syria Laperche, C. Micha Nübling, Susan L. Stramer, Ewa Brojer, Piotr Grabarczyk, Hiroshi Yoshizawa, Vytenis Kalibatas, Magdy El Elkyabi, Faten Moftah, Annie Girault, Harry van Drimmelen, Michael P. Busch, Nico Lelie, Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples, Transfusion, 2015, 55, 10
  3. 3
    Matthew S. Simon, Jared A. Leff, Ankur Pandya, Melissa Cushing, Beth H. Shaz, David P. Calfee, Bruce R. Schackman, Alvin I. Mushlin, Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States, Transfusion, 2014, 54, 3pt2
  4. 4
    Alex J. Goodell, Evan M. Bloch, Peter J. Krause, Brian Custer, Costs, consequences, and cost-effectiveness of strategies for Babesia microti donor screening of the US blood supply, Transfusion, 2014, 54, 9
  5. 5
    Douglas R. Bish, Ebru K. Bish, Ryan S. Xie, Susan L. Stramer, Going beyond “same-for-all” testing of infectious agents in donated blood, IIE Transactions, 2014, 46, 11, 1147

    CrossRef

  6. 6
    Claude Tayou Tagny, Edward L. Murphy, Jean-Jacques Lefrère, Le groupe de recherches transfusionnelles d’Afrique francophone : bilan des cinq premières années, Transfusion Clinique et Biologique, 2014, 21, 1, 37

    CrossRef

  7. 7
    Saif Ghazi Yaseen, S.A. Ahmed, M.F. Johan, R. Kiron, Aqil Mohammad Daher, Evaluation of serological transfusion-transmitted viral diseases and mutliplex nucleic acid testing in malaysian blood donors, Transfusion and Apheresis Science, 2013, 49, 3, 647

    CrossRef

  8. 8
    J. C. Lai, J. G. Kahn, M. Tavakol, M. G. Peters, J. P. Roberts, Reducing Infection Transmission in Solid Organ Transplantation Through Donor Nucleic Acid Testing: A Cost-Effectiveness Analysis, American Journal of Transplantation, 2013, 13, 10
  9. 9
    Lei Chang, Linan Song, David R. Fournier, Cheuk W. Kan, Purvish P. Patel, Evan P. Ferrell, Brian A. Pink, Kaitlin A. Minnehan, David W. Hanlon, David C. Duffy, David H. Wilson, Simple diffusion-constrained immunoassay for p24 protein with the sensitivity of nucleic acid amplification for detecting acute HIV infection, Journal of Virological Methods, 2013, 188, 1-2, 153

    CrossRef

  10. You have free access to this content10
    S. Laperche, Testing for established viruses: from the screening to the confirmation, ISBT Science Series, 2013, 8, 1
  11. 11
    Server Yagci, Elizaveta Padalko, Comparison of Monolisa HCV Ag/Ab ULTRA With Two Anti-HCV Assays For the Detection of HCV Infection in Hospital Setting, Current Microbiology, 2012, 64, 2, 148

    CrossRef

  12. 12
    Barbara A. Borkent-Raven, Mart P. Janssen, Cees L. van der Poel, Gouke J. Bonsel, Ben A. van Hout, Cost-effectiveness of additional blood screening tests in the Netherlands, Transfusion, 2012, 52, 3
  13. 13
    Conor Teljeur, Martin Flattery, Patricia Harrington, Michelle O'Neill, Patrick S. Moran, Linda Murphy, Máirín Ryan, Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland, Transfusion, 2012, 52, 11
  14. 14
    Brian S. Custer, Good evidence begets good policy: or so it should be, Transfusion, 2012, 52, 3
  15. 15
    Yen-Hsuan Ni, Mei-Hwei Chang, Jia-Feng Wu, Hong-Yuan Hsu, Huey-Ling Chen, Ding-Shinn Chen, Minimization of hepatitis B infection by a 25-year universal vaccination program, Journal of Hepatology, 2012, 57, 4, 730

    CrossRef

  16. 16
    Rohit Jain, Pankaj Aggarwal, Gajendra Nath Gupta, Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections, ISRN Hematology, 2012, 2012, 1

    CrossRef

  17. 17
    Shiguang R. Xie, Douglas R. Bish, Ebru K. Bish, Anthony D. Slonim, Susan L. Stramer, Safety and waste considerations in donated blood screening, European Journal of Operational Research, 2012, 217, 3, 619

    CrossRef

  18. 18
    Nicholas A. Watkins, Stephen Dobra, Peter Bennett, John Cairns, Marc L. Turner, The Management of Blood Safety in the Presence of Uncertain Risk: A United Kingdom Perspective, Transfusion Medicine Reviews, 2012, 26, 3, 238

    CrossRef

  19. 19
    Jay P. Brooks, Using Basic Ethical Principles to Evaluate Safety Efforts in Transfusion Medicine, Journal of Blood Transfusion, 2012, 2012, 1

    CrossRef

  20. 20
    Heather Hsu, Rochelle P. Walensky, Cost-effectiveness Analysis and HIV Screening: The Emergency Medicine Perspective, Annals of Emergency Medicine, 2011, 58, 1, S145

    CrossRef

  21. You have free access to this content21
    J. E. Levi, Current concepts in molecular testing, ISBT Science Series, 2011, 6, 1
  22. 22
    Jean-Jacques Lefrère, Honorine Dahourouh, Alexis E. Dokekias, Maxime D. Kouao, Amadou Diarra, Saliou Diop, Jean-Baptiste Tapko, Edward L. Murphy, Syria Laperche, Josiane Pillonel, Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study, Transfusion, 2011, 51, 3
  23. 23
    David Juhl, Jürgen Luhm, Siegfried Görg, Malte Ziemann, Holger Hennig, Evaluation of algorithms for the diagnostic assessment and the reentry of blood donors who tested reactive for antibodies against hepatitis B core antigen, Transfusion, 2011, 51, 7
  24. 24
    Lauren M Kucirka, Andrew L Singer, Dorry L Segev, High infectious risk donors: what are the risks and when are they too high?, Current Opinion in Organ Transplantation, 2011, 16, 2, 256

    CrossRef

  25. 25
    Suda Louisirirotchanakul, Sineenart Oota, Kalayanee Khuponsarb, Wilai Chalermchan, Soisaang Phikulsod, Viroje Chongkolwatana, Tasanee Sakuldamrongpanish, Pimpun Kitpoka, Pimol Chielsilp, Srivilai Tanprasert, Thaweesak Tirawatnapong, Chantapong Wasi, Occult hepatitis B virus infection in Thai blood donors, Transfusion, 2011, 51, 7
  26. 26
    Douglas R. Bish, Ebru K. Bish, Shiguang R. Xie, Anthony D. Slonim, Optimal selection of screening assays for infectious agents in donated blood, IIE Transactions on Healthcare Systems Engineering, 2011, 1, 2, 67

    CrossRef

  27. 27
    Susanne Marschner, Raymond Goodrich, Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light, Transfusion Medicine and Hemotherapy, 2011, 38, 1, 8

    CrossRef

  28. 28
    Susan L. Stramer, David E. Krysztof, Jaye P. Brodsky, Tracy A. Fickett, Benjamin Reynolds, Soisaange Phikulsod, Sineeart Oota, Matthew Lin, John Saldanha, Steven H. Kleinman, Sensitivity comparison of two Food and Drug Administration–licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield, Transfusion, 2011, 51, 9
  29. 29
    Thomas Davidson, Bengt Ekermo, Hans Gaines, Birgitta Lesko, Britt Åkerlind, The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden, Transfusion, 2011, 51, 2
  30. 30
    Teresa Shafer, David Schkade, Lawrence Schkade, Steven Geier, Jeffrey Orlowski, Goran Klintmalm, Zero risk tolerance costs lives: loss of transplantable organs due to human immunodeficiency virus nucleic acid testing of potential donors, Progress in Transplantation, 2011, 21, 3, 236

    CrossRef

  31. 31
    Margreet C. van Eerd, J.N. Mario Ouwens, Maria A. de Peuter, Cost-effectiveness study comparing pharmaceutically licensed plasma for transfusion (OctaplasLG®) versus fresh frozen plasma (FFP) in critically Ill patients in the UK, Transfusion and Apheresis Science, 2010, 43, 3, 251

    CrossRef

  32. 32
    Mads Kamper-Jørgensen, Henrik Hjalgrim, Gustaf Edgren, Kjell Titlestad, Henrik Ullum, Agneta Shanwell, Marie Reilly, Mads Melbye, Olof Nyrén, Klaus Rostgaard, Expensive blood safety initiatives may offer less benefit than we think, Transfusion, 2010, 50, 1
  33. 33
    Harvey G. Klein, How safe is blood, really?, Biologicals, 2010, 38, 1, 100

    CrossRef

  34. 34
    A. Humar, M. Morris, E. Blumberg, R. Freeman, J. Preiksaitis, B. Kiberd, E. Schweitzer, S. Ganz, A. Caliendo, J. P. Orlowski, B. Wilson, C. Kotton, M. Michaels, S. Kleinman, S. Geier, B. Murphy, M. Green, M. Levi, G. Knoll, D. Segev, S. Brubaker, R. Hasz, D. J. Lebovitz, D. Mulligan, K. O’Connor, T. Pruett, M. Mozes, I. Lee, F. Delmonico, S. Fischer, Nucleic Acid Testing (NAT) of Organ Donors: Is the ‘Best’ Test the Right Test? A Consensus Conference Report, American Journal of Transplantation, 2010, 10, 4
  35. 35
    Brian Custer, Maria Agapova, Rebecca Havlir Martinez, The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model, Transfusion, 2010, 50, 11
  36. 36
    Brian Custer, Jeffrey S. Hoch, Cost-Effectiveness Analysis: What It Really Means for Transfusion Medicine Decision Making, Transfusion Medicine Reviews, 2009, 23, 1, 1

    CrossRef

  37. 37
    B.A. Borkent-Raven, M.P. Janssen, C.L. Van Der Poel, G.A. De Wit, G.J. Bonsel, B.A. Van Hout, Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands, Transfusion, 2009, 49, 2
  38. You have free access to this content38
    L. C. Ng, S. Lam, D. Teo, Epidemiology of dengue and chikungunya viruses and their potential impact on the blood supply, ISBT Science Series, 2009, 4, n2
  39. 39
    D. Teo, L. C. Ng, S. Lam, Is dengue a threat to the blood supply?, Transfusion Medicine, 2009, 19, 2
  40. 40
    Michael Busch, Mark Walderhaug, Brian Custer, Jean-Pierre Allain, Ravi Reddy, Brian McDonough, Risk assessment and cost-effectiveness/utility analysis, Biologicals, 2009, 37, 2, 78

    CrossRef

  41. 41
    Syria Laperche, Geneviève Boukatou, Léonard Kouegnigan, Yacouba Nébié, Mohamed Ould Boulahi, Claude Tayou Tagny, Rakia Yahaya, Jean-Baptiste Tapko, Edward Murphy, Jean Jacques Lefrère, Transfusion safety on the African continent: an international quality control of virus testing in blood banks, Transfusion, 2009, 49, 8
  42. 42
    Aryeh Shander, Lawrence Tim Goodnough, Why an Alternative to Blood Transfusion?, Critical Care Clinics, 2009, 25, 2, 261

    CrossRef

  43. 43
    Syria Laperche, Antigen-antibody combination assays for blood donor screening: weighing the advantages and costs, Transfusion, 2008, 48, 4
  44. 44
    Scott D Grosse, Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold, Expert Review of Pharmacoeconomics & Outcomes Research, 2008, 8, 2, 165

    CrossRef

  45. 45
    Marinus Van Hulst, Kwamena W. C. Sagoe, Jacobien E. Vermande, Ido P. Van Der Schaaf, Willem P. A. Van Der Tuuk Adriani, Kwasi Torpey, Justina Ansah, Julius A. A. Mingle, Cees Th. Smit Sibinga, Maarten J. Postma, Cost-Effectiveness of HIV Screening of Blood Donations in Accra (Ghana), Value in Health, 2008, 11, 5
  46. 46
    Hamish Mohammed, Jeffrey M. Linnen, Jorge L. Muñoz-Jordán, Kay Tomashek, Gregory Foster, Amy S. Broulik, Lyle Petersen, Susan L. Stramer, Dengue virus in blood donations, Puerto Rico, 2005, Transfusion, 2008, 48, 7
  47. 47
    Jay P. Brooks, Quality Improvement Opportunities in Blood Banking and Transfusion Medicine, Clinics in Laboratory Medicine, 2008, 28, 2, 321

    CrossRef

  48. 48
    Christina Maresch, Philip J. Schluter, Andrew D. Wilson, Adrian Sleigh, Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil, Transfusion, 2008, 48, 2
  49. 49
    Mads Kamper-Jørgensen, Martin Ahlgren, Klaus Rostgaard, Mads Melbye, Gustaf Edgren, Olof Nyrén, Marie Reilly, Rut Norda, Kjell Titlestad, Elsa Tynell, Henrik Hjalgrim, Survival after blood transfusion, Transfusion, 2008, 48, 12
  50. 50
    Joseph Ahn, Stanley M. Cohen, Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation, Liver Transplantation, 2008, 14, 11
  51. 51
    J. Paul Leigh, Marion Gillen, Peter Franks, Susan Sutherland, Hien H. Nguyen, Kyle Steenland, Guibo Xing, Costs of needlestick injuries and subsequent hepatitis and HIV infection, Current Medical Research and Opinion, 2007, 23, 9, 2093

    CrossRef

  52. 52
    J. P. AuBuchon, Government, media and decision making in blood transfusion, ISBT Science Series, 2007, 2, 1
  53. 53
    C. Angelotta, J. M. McKoy, M. J. Fisher, C. G. Buffie, K. Barfi, G. Ramsey, L. Frohlich, C. L. Bennett, Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia, Vox Sanguinis, 2007, 93, 2
  54. 54
    Scott D. Grosse, Steven M. Teutsch, Anne C. Haddix, Lessons from Cost-Effectiveness Research for United States Public Health Policy*, Annual Review of Public Health, 2007, 28, 1, 365

    CrossRef

  55. 55
    Gary Zeger, Eileen Selogie, Ira A. Shulman, Blood Banking and Transfusion Medicine, 2007,

    CrossRef

  56. 56
    K. Moeremans, H. Warie, L. Annemans, Assessment of the economic value of the INTERCEPT blood system in Belgium, Transfusion Medicine, 2006, 16, 1
  57. 57
    Chyang T. Fang, Blood Screening for HBV DNA, Journal of Clinical Virology, 2006, 36, S30

    CrossRef

  58. 58
    Caroline T Korves, Sue J Goldie, Megan B Murray, Farzad Mostashari, Cost-Effectiveness of Alternative Blood-Screening Strategies for West Nile Virus in the United States, PLoS Medicine, 2006, 3, 2, e21

    CrossRef

  59. 59
    Chun-Jen Liu, Ding-Shinn Chen, Pei-Jer Chen, Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT, Journal of Clinical Virology, 2006, 36, S33

    CrossRef

  60. 60
    Mary C. Kuhns, Michael P. Busch, New Strategies for Blood Donor Screening for Hepatitis B Virus, Molecular Diagnosis & Therapy, 2006, 10, 2, 77

    CrossRef

  61. 61
    Ruth Offergeld, Sabine Ritter, Osamah Hamouda, The Risk of Transfusion Transmitted Infections – Current Aspects*, Transfusion Medicine and Hemotherapy, 2006, 33, 2, 130

    CrossRef

  62. 62
    Michael P. Busch, Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis, Transfusion, 2006, 46, 9
  63. 63
    Chun-Jen Liu, Shyh-Chyi Lo, Jia-Horng Kao, Ping-Tsung Tseng, Ming-Yang Lai, Yen-Hsuan Ni, Shiou-Hwei Yeh, Pei-Jer Chen, Ding-Shinn Chen, Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan, Journal of Hepatology, 2006, 44, 1, 39

    CrossRef

  64. 64
    Keiko Tomioka, Michael Peredelchuk, Xiangyang Zhu, Roberto Arena, Dmitri Volokhov, Angamuthu Selvapandiyan, Katie Stabler, Jenny Mellquist-Riemenschneider, Vladimir Chizhikov, Gerardo Kaplan, Hira Nakhasi, Robert Duncan, A Multiplex Polymerase Chain Reaction Microarray Assay to Detect Bioterror Pathogens in Blood, The Journal of Molecular Diagnostics, 2005, 7, 4, 486

    CrossRef

  65. 65
    S.H. Kleinman, D.M. Strong, G.G.E. Tegtmeier, P.V. Holland, J.B. Gorlin, C. Cousins, R.P Chiacchierini, L.A. Pietrelli, Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test, Transfusion, 2005, 45, 8
  66. 66
    Syria Laperche, Marie-Hélène Elghouzzi, Pascal Morel, Marianne Asso-Bonnet, Nadine Le Marrec, Annie Girault, Annabelle Servant-Delmas, Françoise Bouchardeau, Marie Deschaseaux, Yves Piquet, Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?, Transfusion, 2005, 45, 12
  67. 67
    Nahum M�ndez-S�nchez, Guadalupe Ponciano-Rodriguez, Norberto C. Ch�vez-Tapia, Daniel Motola-Kuba, Paloma Almeda-Valdes, Karla S�nchez-Lara, Martha H. Ramos, Misael Uribe, Prevalence of Hepatitis C Infection in a Population of Asymptomatic People in a Checkup Unit in Mexico City, Digestive Diseases and Sciences, 2005, 50, 4, 733

    CrossRef

  68. 68
    Jay P. Brooks, Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products, Transfusion, 2005, 45,
  69. 69
    Michael P. Busch, Simone A. Glynn, David J. Wright, Dale Hirschkorn, Megan E. Laycock, Joan McAuley, Yongling Tu, Cristina Giachetti, James Gallarda, John Heitman, Steven H. Kleinman, Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection, Transfusion, 2005, 45, 12
  70. 70
    C. R. Seed, P. Kiely, A. J. Keller, Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus, Internal Medicine Journal, 2005, 35, 10
  71. 71
    Michael P. Busch, Sally Caglioti, Eugene F. Robertson, Joan D. McAuley, Leslie H. Tobler, Hany Kamel, Jeffrey M. Linnen, Venkatakrishna Shyamala, Peter Tomasulo, Steven H. Kleinman, Screening the Blood Supply for West Nile Virus RNA by Nucleic Acid Amplification Testing, New England Journal of Medicine, 2005, 353, 5, 460

    CrossRef

  72. 72
    Susan L. Stramer, Simone A. Glynn, Steven H. Kleinman, D. Michael Strong, Sally Caglioti, David J. Wright, Roger Y. Dodd, Michael P. Busch, Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing, New England Journal of Medicine, 2004, 351, 8, 760

    CrossRef

  73. 73
    Steven Kleinman, Deborah Marshall, James AuBuchon, Mary Patton, Survival after transfusion as assessed in a large multistate US cohort, Transfusion, 2004, 44, 3
  74. 74
    J. P. Brooks, The rights of blood recipients should supersede any asserted rights of blood donors, Vox Sanguinis, 2004, 87, 4
  75. 75
    Jesse L. Goodman, The Safety and Availability of Blood and Tissues — Progress and Challenges, New England Journal of Medicine, 2004, 351, 8, 819

    CrossRef

  76. 76
    John Fung, Koji Hashimoto, Bijan Eghtesad, Daniel J. Lebovitz, Melissa Watson, Deceased Donor Management,
  77. 77
    Peter Simmonds, David Mutimer, Hepatitis C Virus, Topley and Wilson's Microbiology and Microbial Infections,